[CUSIP No. 16938C106 13D 1 Essence International Investment Limited NAMES OF REPORTING PERSONS: N/A I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS WC 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands NUMBER OF SHARES BENEFICIALLY]
[CUSIP No. 16938C106 13D 1 Essence International Investment Limited NAMES OF REPORTING PERSONS: N/A I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS WC 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands NUMBER OF SHARES BENEFICIALLY]
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-9]
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-9]
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-9]
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-9]
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-9]
[CHINA BIOLOGIC PRODUCTS, INC. UNDERWRITING AGREEMENT June 27, 2014 June 27, 2014 Morgan Stanley & Co. International plc for the Underwriters named in Schedule II hereto Ladies and Gentlemen: Company Underwriters Manager Selling Stockholder Firm Shares Company Additional Shares Selling Stockholder Additional Shares Additional Shares Shares. Common Stock Sellers China Biologic Products, Inc., a Delaware corporation (the “ Commission Shelf] [China Biologic Announces Pricing of Public Offering of Common Stock BEIJING, China – June 27, 2014 The Company intends to use the proceeds from the offering primarily for general corporate purposes. In addition, if appropriate opportunities arise in the future to acquire or invest in complementary businesses, products or technologies, the Company may use a portion of the net proceeds] []
